The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

In the trial, efsitora met the primary endpoint of non-inferior A1C reduction. For the efficacy estimand, efsitora reduced A1C by 1.34% compared to 1.26% for insulin degludec resulting in an A1C of ...

The World Health Organization issued a warning last year about insulin pens relabeled and repackaged to look like Ozempic.

Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles (400 km) to Mexico to buy cheap Ozempic to help ...

A pair of late-stage trials found that Eli Lilly & Co.’s experimental once-weekly insulin can lower blood sugar as effectively as widely used daily insulins, the drugmaker said Thursday ...